Evidence map›Paper›PMID 18516302›Full record

ArticlePLoS pathogens2008

Varicellovirus UL 49.5 proteins differentially affect the function of the transporter associated with antigen processing, TAP.

Danijela Koppers-Lalic, Marieke C Verweij, Andrea D Lipińska, Ying Wang, Edwin Quinten, Eric A Reits, Joachim Koch, Sandra Loch, Marisa Marcondes Rezende, Franz Daus and 10 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 87 citations in OpenAlex.

  1. Review
  2. Structurally diverse viral inhibitors converge on a shared mechanism to stall the antigen transporter TAP.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. A Structural Atlas of TAP Inhibition by Herpesviruses and Poxviruses.bioRxiv : the preprint server for biology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Bovine Herpesvirus 1 UJournal of virology · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Cowpox virus protein CPXV012 eludes CTLs by blocking ATP binding to TAP.Journal of immunology (Baltimore, Md. : 1950) · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 4 countries.

Danijela Koppers-LalicCenter of Infectious Diseases and Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
Marieke C Verweij
Andrea D Lipińska
Ying Wang
Edwin Quinten
Eric A Reits
Joachim Koch
Sandra Loch
Marisa Marcondes Rezende
Franz Daus
Krystyna Bieńkowska-Szewczyk
Nikolaus Osterrieder
Thomas C Mettenleiter
Mirjam H M Heemskerk
Robert Tampé
Jacques J Neefjes
Shafiqul I Chowdhury
Maaike E Ressing
Frans A M Rijsewijk
Emmanuel J H J Wiertz
Leiden University Medical Center · NLGoethe University Frankfurt · DEKansas State University · USUniversity of Gdańsk · PLAcademic Medical Center · NLCornell University · USInstitute of Molecular Biology · DEThe Netherlands Cancer Institute · NL

Funding

In vivo effects of MHCI down regulation in HerpesvirusesR56AI063048 · NIAID · CORNELL UNIVERSITY · PI OSTERRIEDER, NIKOLAUS · 2006 to 2006
$311k
NIAID NIH HHS AI063048NIAID NIH HHS R56 AI063048
6 · The paper itself

Abstract

Cytotoxic T-lymphocytes play an important role in the protection against viral infections, which they detect through the recognition of virus-derived peptides, presented in the context of MHC class I molecules at the surface of the infected cell. The transporter associated with antigen processing (TAP) plays an essential role in MHC class I-restricted antigen presentation, as TAP imports peptides into the ER, where peptide loading of MHC class I molecules takes place. In this study, the UL 49.5 proteins of the varicelloviruses bovine herpesvirus 1 (BHV-1), pseudorabies virus (PRV), and equine herpesvirus 1 and 4 (EHV-1 and EHV-4) are characterized as members of a novel class of viral immune evasion proteins. These UL 49.5 proteins interfere with MHC class I antigen presentation by blocking the supply of antigenic peptides through inhibition of TAP. BHV-1, PRV, and EHV-1 recombinant viruses lacking UL 49.5 no longer interfere with peptide transport. Combined with the observation that the individually expressed UL 49.5 proteins block TAP as well, these data indicate that UL 49.5 is the viral factor that is both necessary and sufficient to abolish TAP function during productive infection by these viruses. The mechanisms through which the UL 49.5 proteins of BHV-1, PRV, EHV-1, and EHV-4 block TAP exhibit surprising diversity. BHV-1 UL 49.5 targets TAP for proteasomal degradation, whereas EHV-1 and EHV-4 UL 49.5 interfere with the binding of ATP to TAP. In contrast, TAP stability and ATP recruitment are not affected by PRV UL 49.5, although it has the capacity to arrest the peptide transporter in a translocation-incompetent state, a property shared with the BHV-1 and EHV-1 UL 49.5. Taken together, these results classify the UL 49.5 gene products of BHV-1, PRV, EHV-1, and EHV-4 as members of a novel family of viral immune evasion proteins, inhibiting TAP through a variety of mechanisms.

Indexed as

AnimalsAntigen PresentationATP-Binding Cassette TransportersCattleCell Line, TumorCell SurvivalDogsHerpesvirus 1, BovineHerpesvirus 1, EquidHerpesvirus 1, SuidHorsesHumansProtein TransportRecombination, GeneticSwineTransduction, GeneticATP-Binding Cassette Transporterstransporter associated with antigen processing (TAP)UL49.5 protein, bovine herpesvirus type 1Viral Envelope Proteins

Identifiers

PMID18516302
PMCPMC2386557
OpenAlexW2141208006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.